Data / Form D filings / CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc.: Form D filing
CNS Pharmaceuticals, Inc., a pharmaceuticals company in Houston, TX, filed a Form D with the SEC in 2026. The latest, on May 19, 2026, reports $22.5 million sold of a $22.5 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2100 WEST LOOP SOUTH SUITE 900, Houston, TX, 77027
- Phone
- (800) 946-9185
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1729427
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | New notice | $22,525,000 | $22,525,000 | 13 | May 4, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rami Levin | Executive Officer, Director | |
| Steve O'Loughlin | Executive Officer | |
| Faith Charles | Director | |
| Michal Fisher | Director | |
| Jeffry Keyes | Director | |
| Bettina Cockroft | Director | |
| Amy Mahery | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
- InnovoTEX Inc. $749,951 · Aug 6, 2026
Every Form D from the week of May 18, 2026 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CNS Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.